Veeva Vault Clinical alternatives for teams that don't need the full life sciences cloud

If you don't need the full Vault stack across commercial, regulatory, and clinical, Vault Clinical on its own is a heavy commitment. WeGuide covers eCOA, eConsent, wearables, and a whitelabel participant app in one regulatory-grade platform, built for academic research, CROs, and mid-market sponsors.

No pressure, no hard sell. A 30-minute walkthrough with a research colleague who's built platforms like yours.

vs

Where WeGuide differs

  • Clinical layer only, not a life sciences platform commitment

  • No code configuration without dedicated administrators

  • Whitelabel mobile apps under your own brand

Used by leading research and medical institutes.

Why research teams look for a Veeva Clinical alternative

The short version

The Veeva Clinical conversation usually goes like this. A mid-market sponsor or academic CRO wants clinical trial software. They hear Vault Clinical is the modern alternative to Medidata Rave. They book a call. And they discover Vault Clinical is priced and delivered as part of Veeva's enterprise Vault platform, which assumes you already run Veeva across the rest of the organisation, or that you're willing to invest in dedicated Vault administrators to stand it up.

Why teams look elsewhere

For a top-20 pharma sponsor that already runs Vault CRM across the commercial team, Vault QMS in quality, and Vault RIM in regulatory affairs, adding Vault Clinical makes complete sense. The integration story is real, the data flows make sense, and the Veeva relationship is already there. For sponsors who aren't running Vault anywhere else, the clinical suite becomes a significant standalone commitment with enterprise pricing attached.

The other recurring gap is patient engagement depth. MyVeeva for Patients unifies eCOA, eConsent, and virtual visits in a single app, which is a real step forward from older fragmented tools. What it doesn't have is whitelabel branding under the sponsor's own name, native wearable integration, patient registries, employee wellbeing programmes, or the continuous engagement architecture (push notifications, in-app messaging, study companion) that drives high adherence over long-duration studies. For sponsors who need the participant relationship to be the centre of the study, MyVeeva is typically a foundation rather than the full solution.

WeGuide is built for the clinical layer only. No commercial CRM, no regulated content management, no broader Vault platform. Just patient engagement and clinical trial technology, configured by the sponsor's own research team, without a Vault administrator contract.

Key differences between WeGuide and Veeva

For teams that need the clinical layer without the rest of the Vault platform, here's what changes when you move to WeGuide.

Clinical layer only, not a life sciences platform commitment

Veeva is a full life sciences cloud platform. WeGuide is a clinical trial and patient engagement platform. For sponsors who don't run Vault CRM or Vault QMS elsewhere in the organisation, buying into Veeva typically means committing to a broader vendor relationship. WeGuide is a clinical layer you can adopt on its own without changing the rest of your commercial or regulatory software stack.

No code configuration without dedicated administrators

Veeva implementations typically need dedicated Vault administrators to stand up the platform, configure studies, and manage daily operations. WeGuide is configured by the sponsor's own research team through a no-code programme builder. You don't need a certified administrator or a project manager. For mid-market sponsors, this removes the biggest hidden cost of running Veeva Clinical.

Whitelabel mobile apps under your own brand

MyVeeva for Patients is a capable participant facing app, but it carries the Veeva brand. WeGuide ships native iOS and Android apps fully branded under your organisation's name and identity. The app becomes the study's home for the participant, which is a big part of how WeGuide keeps participants engaged. For branded studies, branding matters. Participants see your organisation, not your vendor.
Compare

Full comparison: WeGuide vs Veeva Clinical

REDCap
REDCap
Primary use case
Patient engagement platform with eCOA, eConsent, wearables, registries
Clinical layer of the broader Vault life sciences cloud
Target customer
Mid-market sponsors, academic CROs, digital health programmes, registries
Enterprise pharma running Vault across commercial, regulatory, quality, and clinical
Configuration model
No-code programme builder, self-service by research teams
Dedicated Vault administrators, enterprise implementation projects
Typical deployment time
Typically two to four weeks of configuration
Enterprise implementation cycles, typically multi-month
Pricing model
Project-based, all modules included
Enterprise annual contracts, typically tied to broader Vault commitments
Whitelabel mobile app
Yes, fully branded under your organisation
MyVeeva for Patients carries Veeva branding
eCOA and ePRO
Native with a validated instrument library
MyVeeva for Patients covers eCOA and ePRO
Wearable integration
Native Garmin, Apple Health, Health Connect, and Fitbit Air
Supported through partner integrations
Telehealth and virtual visits
Built-in video visit and virtual site features
MyVeeva for Patients covers virtual visits
Patient registry
Built-in longitudinal registry (GenV: about 124,000 people)
Not a native use case
Employee wellbeing and population health
Built in
Outside the platform's scope
EDC
Form Builder covers eCRF use cases, deeper capture via Integration Engine
Vault EDC, a direct Medidata Rave competitor with strong Vault-customer adoption
Life sciences cloud breadth
Clinical and participant layer only
Full Vault platform: CRM, QMS, RIM, PromoMats, Clinical
Multi-language translation management
Built-in (INHERIT study proof)
Available in enterprise Vault
Regulatory certification
TGA Class I medical device, ISO 27001, 21 CFR Part 11, HIPAA, GDPR
21 CFR Part 11 and broad regulatory compliance across Vault
Australian data residency
Yes
Regional options via Veeva global infrastructure
REDCap
REDCap

Top alternatives to Veeva Clinical in 2026

Here's the shortlist of platforms most teams evaluate when they're looking at Vault Clinical, Vault EDC, or MyVeeva for Patients and want to compare real alternatives.

Where WeGuide goes further

For teams that want the participant side of a study in one platform, here's what changes when you move to WeGuide.

Clinical layer only, not a life sciences platform commitment

Veeva is a full life sciences cloud platform. WeGuide is a clinical trial and patient engagement platform. For sponsors who don't run Vault CRM, Vault QMS, or Vault RIM anywhere else in the organisation, buying into Vault Clinical typically means committing to Veeva as a broader vendor relationship. WeGuide is a clinical layer you can adopt on its own without changing the rest of your commercial, quality, or regulatory software stack.

‍

No-code configuration without dedicated administrators

Veeva Clinical implementations typically need dedicated Vault administrators to stand up the platform, configure studies, and manage day-to-day operations. WeGuide is configured by the sponsor's own research team through a no-code programme builder. You don't need a certified Vault administrator on staff and you don't need an enterprise implementation project manager. For mid-market sponsors and academic CROs that can't justify a full Vault administration role, this removes the biggest hidden cost of running Veeva Clinical. See the Form Builder →

Mid-market accessibility

Vault Clinical is priced as part of the enterprise Vault platform, typically with annual contracts that assume an enterprise customer profile. WeGuide is project-based and scales to the study's actual complexity, with every module (eCOA, eConsent, registry, telehealth, wearables, analytics) included in the core licence. For mid-market biotech, academic research, and investigator-led studies, that's typically the difference between being able to afford the platform and not.

Whitelabel mobile apps under your own brand

MyVeeva for Patients is a capable participant-facing app, but it carries the Veeva brand. WeGuide ships native iOS and Android apps fully branded under your organisation's name and identity. For sponsor-branded studies, patient registries, and digital health programmes where the app becomes the home of the study for the participant, that branding matters. Participants see your organisation, not your vendor.

Native wearable SDK

Garmin, Apple Health, Health Connect and Fitbit Air integrations are built directly into WeGuide. Participants connect their devices once and data syncs automatically into the study database. Veeva supports wearables through partner integrations, which works but adds procurement overhead. See supported wearable devices →

Deploy in weeks, not enterprise cycles

With WeGuide, configuration alongside your team typically takes two to four weeks. Vault Clinical implementations are enterprise projects and typically run multi-month because of the administrator-led delivery model. For sponsors where time to first patient matters, that's a significant delivery-model difference.

Patient registries and employee wellbeing

Vault Clinical is scoped to clinical trials. WeGuide covers a wider set of research use cases: patient registries (GenV: about 124,000 Victorians), employee wellbeing programmes, population health, paediatric cardiac monitoring (Beat2Beat), and multilingual community health studies (INHERIT). If your programme includes more than traditional trials, running everything on one platform changes the total cost and operational picture. See WeGuide's patient registry platform →

Multi-language translation management

WeGuide ships with dynamic translation management that's been proven on the INHERIT multilingual COVID-19 study across diverse community populations. Translations apply to eCOA instruments, consent flows, and engagement content, not just static form labels. See how multi-language support works →

TGA registration and Australian data residency

WeGuide is TGA registered Class I medical device software with Australian data residency. For APAC research, especially Australian investigator-led studies and sponsor programmes, that's a meaningful differentiator that global platforms can't match without a local hosting partner.

Built for regulated research

Every WeGuide study runs on our managed infrastructure. Your IT team doesn't patch servers, manage backups, or run disaster recovery drills.

TGA Registered

Registered Class I medical device software with the Therapeutic Goods Administration.

ISO 27001

Certified information security management covering access, audit, and incident response.

Data Hosted in Australia

Participant data is hosted in Australian data centres with sovereign data controls.

GDPR Compliant

GDPR, HIPAA, and 21 CFR Part 11 ready for multi-country and US-based studies.

Biometric Security

Participant access protected by PIN code and biometric authentication on device.

256-bit AES Encryption

All data encrypted at rest and in transit with automated backups and disaster recovery.

Where Veeva excels

Market-leading life sciences cloud. Vault is the industry standard for regulated documents and data across commercial, quality, regulatory, and clinical. For enterprise pharma that wants one platform across the entire life sciences operation, Veeva's breadth is unmatched. Vault CRM runs the commercial team, Vault QMS runs quality, Vault RIM runs regulatory affairs, Vault PromoMats runs promotional content, and Vault Clinical runs trials, all on the same regulated-document backbone with genuine cross-platform integration.

Deep Vault integration across the stack. The integration story between Vault modules is real. For Vault customers already running commercial, quality, and regulatory workflows, adding Vault Clinical means data flows into a stack their organisation already knows. That continuity is a genuine strength and not something a standalone clinical platform can replicate.

Vault EDC as a direct Rave competitor. Vault EDC has earned real market share as a modern alternative to Medidata Rave, especially for sponsors already on the Vault platform. For teams that want enterprise eCRF depth with cloud-native architecture, Vault EDC is a capable and regulator-accepted product. WeGuide does not replace Vault EDC for deep eCRF use cases.

MyVeeva for Patients unifies eCOA, eConsent, and visits. MyVeeva for Patients is a genuine step forward from older fragmented eCOA and eConsent vendors. Sponsors who want the three core participant-facing functions in one Veeva-supported app find MyVeeva a solid foundation.

Enterprise support and roadmap stability. Veeva is publicly traded with a $30B+ market cap. For enterprise sponsors whose procurement and risk teams need long-term vendor stability, Veeva's size and financial position are genuine advantages.

If your organisation already runs Vault across commercial, quality, and regulatory, adding Vault Clinical is a defensible choice and we'd rather say that honestly than pitch WeGuide into a study where Veeva's integrated stack makes more sense.

WeGuide runs alongside Veeva Vault

‍

If your organisation already runs Vault Clinical or Vault EDC for core clinical data management, you don't have to rip it out to use WeGuide for the participant-facing layer. Our Integration Engine connects to Vault through its APIs, so Veeva handles regulated document management and core EDC while WeGuide runs whitelabel patient engagement, eCOA, eConsent, wearables, registries, and telehealth. Hybrid stacks are common with teams that want Veeva's enterprise Vault depth plus WeGuide's participant experience.

How the switch works

For teams that are evaluating Vault Clinical but want a pure patient-engagement alternative, or for Veeva Vault customers who want to layer WeGuide on top of the existing stack, here's how onboarding typically plays out.

Discovery Call

A 30-minute conversation with one of our research delivery team. We look at your protocol, your current Vault setup, and what's actually blocking you. No sales pitch.

Study Configuration

Our team works alongside yours to configure the study in WeGuide. If you're keeping Vault EDC for core data capture, we configure the Integration Engine at this stage. Typical timeline: two to four weeks.

We Guide

Participant Onboarding

The whitelabel app goes live under your organisation's brand. Research coordinators invite participants, and consent flows, eCOA instruments, and engagement templates are ready.

Ongoing Support

You get a named research delivery contact, not a Vault administrator contract. We stay involved for the life of the study.

Case studies: research teams that wanted the clinical layer, not the full Vault stack

BRACE Trial (Murdoch Children's Research Institute)

An international randomised controlled trial studying whether the BCG vaccine could reduce COVID-19 symptom severity in healthcare workers, run across several countries with thousands of participants. It was a hybrid trial, with in person vaccination and blood collection. MCRI needed fast deployment and participant-facing architecture, not an enterprise Vault implementation project.

GenV (Generation Victoria)

A population health study following roughly 124,000 Victorians (about 50,000 children from birth and 74,000 parents). Longitudinal registry work at this scale sits outside Vault Clinical's scope. The whitelabel family-facing app is the reason retention has held across multiple years.

FSHD Global

A longitudinal patient registry for facioscapulohumeral muscular dystrophy, combining patient reported outcomes with wearable integration. Participants report from home on their own phones, devices sync in the background, and the registry keeps a continuous picture of a rare disease over time instead of a snapshot at each clinic visit.

Helping researchers transform ideas into discoveries.

Hear what our clients have to say!

"GenV trusted WeGuide to run a multi-year population health study with roughly 124,000 Victorians, about 50,000 children and 74,000 parents. Longitudinal engagement at this scale requires push notifications, multi-modal data capture, and a whitelabel app that families will keep on their phones for years.""
Susan Clifford
Susan Clifford
Senior Research Officer
GEN V logo
“The main benefit of WeGuide is its convenience. I can’t imagine how we would follow thousands of participants and collect their data without WeGuide!”
Kaya Gardiner
Kaya Gardiner
Trial Project Manager
Murdoch children Research Institute
"WeGuide has transformed how we manage our patient registry. The ease of digital screening and obtaining eConsent has significantly improved our workflow."
Emma Photo
Emma Weatherley
Managing Director
FSHD Global
"The WeGuide trial offers staff a practical tool for recording daily COVID-19 symptoms and temperatures. For those in high-risk areas, daily reminders and alerts provide peace of mind and reassurance about their health."
KATE Cranwell
Kate Cranwell
Manager
Western Health
"It’s obvious that WeGuide is committed to develop technology that benefits people in the community. WeGuide has been a great partner in achieving this goal within Western Health."
Testimonial Photo
Paul Eleftheriou
Chief Medical Officer
Western Health

Questions

Straight answers on how WeGuide compares to Veeva, what the switch looks like, and when staying on Veeva is the right call.

Contact us

Is WeGuide a full replacement for Veeva Clinical Suite?

Honestly, it depends on your Vault footprint. For top 50 pharma running full regulated clinical commercial integration across Vault CRM, Vault QMS, Vault RIM, and Vault Clinical, Veeva's platform depth is irreplaceable and we won't pretend otherwise. For mid-market sponsors, academic institutions, and CROs that only need clinical trial technology without the full Vault commercial and regulatory stack, WeGuide covers the clinical layer with whitelabel participant engagement, eCOA, eConsent, wearables, telehealth, and registries at a pace and price point that matches mid-market research.

Does WeGuide replace Vault EDC?

No, not for deep eCRF use cases. WeGuide's Form Builder covers participant reported data, eCOA instruments, and engagement workflows with a no-code interface that researchers can use directly. For complex eCRF work with deep edit checks, validation rules, and regulatory grade data capture, Vault EDC (or another dedicated EDC) is the right tool, and our Integration Engine connects to Vault EDC through its APIs so you can run both. We'll tell you honestly on the demo call whether your study needs a standalone EDC alongside WeGuide.

How does MyVeeva for Patients compare to WeGuide?

MyVeeva for Patients unifies eCOA, eConsent, and virtual visits in a single Veeva branded app, which is a real step forward from older fragmented tools. WeGuide covers the same three functions and adds whitelabel branding under your organisation's name, native wearable integration (Garmin, Apple Health, Health Connect, Fitbit Air), continuous engagement architecture (push notifications, in-app messaging, study companion), patient registries, and employee wellbeing and population health use cases that sit outside MyVeeva's scope. Different positioning for different studies.

How does pricing compare?

Veeva Vault Clinical is enterprise priced with annual contracts, typically assuming an enterprise Vault customer profile. Vault EDC, MyVeeva for Patients, and Vault CTMS are often priced as modules within the broader Vault commitment. WeGuide is project based and scales to the study's actual complexity, with every module included in the core licence. For mid-market sponsors and academic research, WeGuide is typically significantly less expensive, and the implementation cost is lower because you don't need a dedicated Vault administrator to stand up the platform.

Can WeGuide coexist with Veeva in a pharma stack?

Yes. Many of the teams we work with run Vault for core EDC, CTMS, or regulated document management and WeGuide for the participant-facing layer. Our Integration Engine connects to Vault through its APIs, so Veeva handles the core clinical data and document workflows while WeGuide runs whitelabel patient engagement, eCOA, eConsent, wearables, and registries. Hybrid architectures are common with enterprise teams that want both.

Is WeGuide 21 CFR Part 11 ready?

Yes, along with TGA Class I medical device certification, ISO 27001, HIPAA, GDPR, and CE marking. Regulatory compliance is part of the core platform, not an enterprise upgrade. For sponsors running FDA facing studies with direct submission requirements, our compliance posture covers the standard regulatory ground, and for Australian investigator-led studies the TGA registration and Australian data residency are genuine differentiators that global platforms can't match without a local hosting partner.

More comparisons

Compare WeGuide with other platforms

Honest, side by side comparisons, grouped by the kind of platform you are weighing up.

See how WeGuide fits your study.

A 30 minute walkthrough with a research colleague, focused on your protocol, your participants and the tools you already run.

Book a demo